Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary updated 2003.

× No keyword cloud information.

108 in total

Review 1. Morphological and functional imaging in COPD with CT and MRI: present and future.

Authors: Julia Ley-Zaporozhan; Sebastian Ley; Hans-Ulrich Kauczor
Journal: Eur Radiol Date: 2007-09-27 Impact factor: 5.315

2. [Outcome predictors for COPD patients hospitalized for acute exacerbation].

Authors: M Spielmanns; F Axer; C Nell; A R Koczulla; T Boeselt; F Magnet; J H Storre; W Windisch
Journal: Med Klin Intensivmed Notfmed Date: 2017-01-02 Impact factor: 0.840

3. GOLD 2011 disease severity classification in COPDGene: a prospective cohort study.

Authors: MeiLan K Han; Hana Muellerova; Douglas Curran-Everett; Mark T Dransfield; George R Washko; Elizabeth A Regan; Russell P Bowler; Terri H Beaty; John E Hokanson; David A Lynch; Paul W Jones; Antonio Anzueto; Fernando J Martinez; James D Crapo; Edwin K Silverman; Barry J Make
Journal: Lancet Respir Med Date: 2012-09-03 Impact factor: 30.700

4. Indacaterol in chronic obstructive pulmonary disease: an update for clinicians.

Authors: Arzu Yorgancioglu
Journal: Ther Adv Chronic Dis Date: 2012-01 Impact factor: 5.091

Review 5. Animal models of chronic obstructive pulmonary disease.

Authors: Joanne L Wright; Manuel Cosio; Andrew Churg
Journal: Am J Physiol Lung Cell Mol Physiol Date: 2008-05-02 Impact factor: 5.464

6. Exposure to cigarette smoke induces overexpression of von Hippel-Lindau tumor suppressor in mouse skeletal muscle.

Authors: Vladimir T Basic; Elsa Tadele; Ali Ateia Elmabsout; Hongwei Yao; Irfan Rahman; Allan Sirsjö; Samy M Abdel-Halim
Journal: Am J Physiol Lung Cell Mol Physiol Date: 2012-07-27 Impact factor: 5.464

7. Ectopic expressed miR-203 contributes to chronic obstructive pulmonary disease via targeting TAK1 and PIK3CA.

Authors: Liang Shi; Qinghong Xin; Ruonan Chai; Lei Liu; Zhuang Ma
Journal: Int J Clin Exp Pathol Date: 2015-09-01

8. Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study.

Authors: Christine R Jenkins; Paul W Jones; Peter M A Calverley; Bartolome Celli; Julie A Anderson; Gary T Ferguson; Julie C Yates; Lisa R Willits; Jörgen Vestbo
Journal: Respir Res Date: 2009-06-30

9. The bioavailability and airway clearance of the steroid component of budesonide/formoterol and salmeterol/fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trial.

Authors: Chris Dalby; Tomasz Polanowski; Thomas Larsson; Lars Borgström; Staffan Edsbäcker; Tim W Harrison
Journal: Respir Res Date: 2009-10-31

10. Soy consumption and risk of COPD and respiratory symptoms: a case-control study in Japan.

Authors: Fumi Hirayama; Andy H Lee; Colin W Binns; Yun Zhao; Tetsuo Hiramatsu; Yoshimasa Tanikawa; Koichi Nishimura; Hiroyuki Taniguchi
Journal: Respir Res Date: 2009-06-26